Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of April 2025. The report specifically details a transaction in the company's own shares executed under a share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 846,648 ordinary shares
- Date of Purchase: April 17, 2025
- Highest Price Paid: 381.50 pence per share
- Lowest Price Paid: 378.20 pence per share
- Volume Weighted Average Price: 379.96 pence per share
- Post-Transaction Registered Share Capital: 9,026,998,743 ordinary shares
- Treasury Shares Held: 4,080,205
- Voting Shares Outstanding: 9,022,918,538
Material Changes
The primary material change is the reduction of outstanding voting shares following the cancellation of 846,648 shares purchased for cancellation. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies. It serves strictly as a regulatory disclosure of a specific share transaction in compliance with the Market Abuse Regulation.
Investor Verification Checklist
- Verify the total number of shares repurchased under the Buyback Programme since its announcement on March 28, 2025.
- Confirm the remaining authorization limit for the share buyback programme.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link.
- Check subsequent filings for updates on the total treasury share count and voting rights.